Haemophilia in France: Modelisation of the Clinical Pathway for Patients

被引:9
作者
Beny, Karen [1 ,2 ]
du Sartz de Vigneulles, Benjamin [1 ]
Carrouel, Florence [1 ]
Bourgeois, Denis [1 ]
Gay, Valerie [3 ]
Negrier, Claude [4 ]
Dussart, Claude [1 ,2 ]
机构
[1] Univ Lyon, Univ Claude Bernard Lyon 1, Fac Med Laennec, Lab P2S Hlth Syst Proc,UR 4129, F-69008 Lyon, France
[2] Hosp Civils Lyon, Cent Pharm, F-69563 St Genis Laval, France
[3] Ctr Hosp Metropole Savoie, Haemophilia Care Ctr, F-73011 Chambery, France
[4] Hosp Civils Lyon, Grp Hosp Est, Reference Ctr Haemophilia & Other Constitut Hemor, F-69002 Lyon, France
关键词
haemophilia; healthcare management; trajectory; course; modeling; EUROPEAN PRINCIPLES; FOLLOW-UP; CARE; COHORT; RECOMMENDATIONS; MANAGEMENT; DIAGNOSIS; LIFE;
D O I
10.3390/ijerph19020646
中图分类号
X [环境科学、安全科学];
学科分类号
08 ; 0830 ;
摘要
Process-of-care studies participate in improving the efficiency of the care pathway for patient with haemophilia (CPPH) and rationalize the multidisciplinary management of patients. Our objective is to establish a current overview of the different actors involved in the management of patients with haemophilia and to provide an accurate description of the patient trajectory. This is a qualitative exploratory research based on interviews of the principal health professionals of four haemophilia services, between November 2019 and February 2020, in France. Mapping of the CPPH processes within the different institutions and/or services, as well as the rupture zones, were identified. Treatment delivery and biological analyses were carried out exclusively in healthcare institutions. The main liberal health professionals solicited were nurses, physiotherapists and general practitioner. Obstacles and barriers within the specialized service, with other hospital services and external hospital or private services, community health care providers et community environment and individual one was complex and multiples. Our research identified potential concerns that need to be addressed to improve future studies to identify influential elements. Similarly, other qualitative studies will have to be conducted on the perceptions and literacy of patients with haemophilia to develop a global interactive mapping of their trajectories.
引用
收藏
页数:14
相关论文
共 42 条
  • [1] Ansteatt KT, 2020, J BLOOD MED, V11, P457, DOI [10.2147/JBH.S289390, 10.2147/JBM.S289390]
  • [2] Diagnosis and care of patients with mild haemophilia: practical recommendations for clinical management
    Benson, Gary
    Auerswald, Guenter
    Dolan, Gerry
    Duffy, Anne
    Hermans, Cedric
    Ljung, Rolf
    Morfini, Massimo
    Salek, Silva Zupancic
    [J]. BLOOD TRANSFUSION, 2018, 16 (06) : 535 - 544
  • [3] Haemophilia
    Berntorp, Erik
    Fischer, Kathelijn
    Hart, Daniel P.
    Mancuso, Maria Elisa
    Stephensen, David
    Shapiro, Amy D.
    Blanchette, Victor
    [J]. NATURE REVIEWS DISEASE PRIMERS, 2021, 7 (01)
  • [4] Clinical, humanistic, and economic burden of severe hemophilia B in the United States: Results from the CHESS US and CHESS US plus population surveys
    Burke, Tom
    Asghar, Sohaib
    O'Hara, Jamie
    Sawyer, Eileen K.
    Li, Nanxin
    [J]. ORPHANET JOURNAL OF RARE DISEASES, 2021, 16 (01)
  • [5] The French haemophilia cohort:: rationale and organization of a long-term national pharmacosurveillance system
    Calvez, T
    Biou, M
    Costagliola, D
    Jullien, AM
    Laurian, Y
    Rossi, F
    Rothschild, C
    Sié, P
    [J]. HAEMOPHILIA, 2001, 7 (01) : 82 - 88
  • [6] Analyses of the FranceCoag cohort support differences in immunogenicity among one plasma-derived and two recombinant factor VIII brands in boys with severe hemophilia A
    Calvez, Thierry
    Chambost, Herve
    d'Oiron, Roseline
    Dalibard, Vincent
    Demiguel, Virginie
    Doncarli, Alexandra
    Gruel, Yves
    Huguenin, Yoann
    Lutz, Patrice
    Rothschild, Chantal
    Vinciguerra, Christine
    Goudemand, Jenny
    [J]. HAEMATOLOGICA, 2018, 103 (01) : 179 - 189
  • [7] Social/economic costs and quality of life in patients with haemophilia in Europe
    Cavazza, Marianna
    Kodra, Yllka
    Armeni, Patrizio
    De Santis, Marta
    Lopez-Bastida, Julio
    Linertova, Renata
    Oliva-Moreno, Juan
    Serrano-Aguilar, Pedro
    Posada-de-la-Paz, Manuel
    Taruscio, Domenica
    Schieppati, Arrigo
    Iskrov, Georgi
    Gulacsi, Laszlo
    Schulenburg, Johann Matthias Graf von der
    Kanavos, Panos
    Chevreul, Karine
    Persson, Ulf
    Fattore, Giovanni
    [J]. EUROPEAN JOURNAL OF HEALTH ECONOMICS, 2016, 17 (01) : 53 - 65
  • [8] What factors influence the age at diagnosis of hemophilia?: Results of the French hemophilia cohort
    Chambost, H
    Gaboulaud, V
    Coatmélec, B
    Rafowicz, A
    Schneider, P
    Calvez, T
    [J]. JOURNAL OF PEDIATRICS, 2002, 141 (04) : 548 - 552
  • [9] Measuring factors affecting implementation of health innovations: a systematic review of structural, organizational, provider, patient, and innovation level measures
    Chaudoir, Stephenie R.
    Dugan, Alicia G.
    Barr, Colin H. I.
    [J]. IMPLEMENTATION SCIENCE, 2013, 8
  • [10] European principles of haemophilia care
    Colvin, B. T.
    Astermark, J.
    Fischer, K.
    Gringeri, A.
    Lassila, R.
    Schramm, W.
    Thomas, A.
    Ingerslev, J.
    [J]. HAEMOPHILIA, 2008, 14 (02) : 361 - 374